Inhibition of hepatocyte growth factor (HGF)-mediated signaling prevents aberrant vascular morphology and ameliorates VEGFR inhibitor resistance in non-small cell lung cancer [125]. This evidence concerns the gene HGF and non-small cell lung carcinoma.